News
For whatever reason, I’ve been home a lot recently.
In a phase 3 clinical trial, chronic night driving impairment in patients who underwent keratorefractive procedures improved ...
Benjamin Bergstrom, DVM, MS, DACVO, helps general practitioners distinguish between these two commonly confused conditions ...
The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic ...
Pharmaceutical Technology on MSN2d
SpyGlass Pharma secures $75m for ophthalmic drug delivery platformSpyGlass Pharma has closed a Series D funding round, raising $75m to advance the company's drug delivery platform to offer ...
The FDA has approved Tryptyr (acoltremon ophthalmic solution) 0.003% for the treatment of the signs and symptoms of dry eye ...
Opus Genetics releases topline results from LYNX-2 evaluating phentolamine ophthalmic solution 0.75%
The phase 3 trial observed the treatment of chronic night driving impairment in keratorefractive patients with reduced ...
Table 01: Global Ophthalmic Drugs Market Volume (Prescriptions in Mn) Forecast, by Dosage Form, 2017-2031 Table 02: Global Ophthalmic Drugs Market Value (US$ Mn) Forecast, by Therapeutic Class, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback